MA51611A - Inhibiteurs de pi4kiiibêta - Google Patents

Inhibiteurs de pi4kiiibêta

Info

Publication number
MA51611A
MA51611A MA051611A MA51611A MA51611A MA 51611 A MA51611 A MA 51611A MA 051611 A MA051611 A MA 051611A MA 51611 A MA51611 A MA 51611A MA 51611 A MA51611 A MA 51611A
Authority
MA
Morocco
Prior art keywords
inhibitors
Prior art date
Application number
MA051611A
Other languages
English (en)
Inventor
Nicholas Paul Barton
Sophie Marie Bertrand
Kenneth Down
Matthew Gray
Original Assignee
Glaxosmithkline Ip Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1800734.4A external-priority patent/GB201800734D0/en
Priority claimed from GBGB1817616.4A external-priority patent/GB201817616D0/en
Application filed by Glaxosmithkline Ip Dev Ltd filed Critical Glaxosmithkline Ip Dev Ltd
Publication of MA51611A publication Critical patent/MA51611A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
MA051611A 2018-01-17 2019-01-15 Inhibiteurs de pi4kiiibêta MA51611A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1800734.4A GB201800734D0 (en) 2018-01-17 2018-01-17 Novel compounds
GBGB1817616.4A GB201817616D0 (en) 2018-10-29 2018-10-29 Novel compounds

Publications (1)

Publication Number Publication Date
MA51611A true MA51611A (fr) 2021-04-21

Family

ID=65033598

Family Applications (1)

Application Number Title Priority Date Filing Date
MA051611A MA51611A (fr) 2018-01-17 2019-01-15 Inhibiteurs de pi4kiiibêta

Country Status (19)

Country Link
US (2) US11649238B2 (fr)
EP (1) EP3740489A1 (fr)
JP (2) JP7133023B2 (fr)
KR (1) KR102523513B1 (fr)
CN (2) CN117069728A (fr)
AR (1) AR114082A1 (fr)
AU (1) AU2019208416B2 (fr)
BR (1) BR112020014431A2 (fr)
CA (1) CA3088347A1 (fr)
CL (1) CL2020001875A1 (fr)
CO (1) CO2020008887A2 (fr)
IL (1) IL276013B2 (fr)
MA (1) MA51611A (fr)
MX (1) MX2020007521A (fr)
PH (1) PH12020551034A1 (fr)
SG (1) SG11202006453SA (fr)
TW (1) TWI795510B (fr)
UY (1) UY38051A (fr)
WO (1) WO2019141694A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020007521A (es) * 2018-01-17 2022-12-05 Glaxosmithkline Ip Dev Ltd Inhibidores de pi4kiii.
EP4125919A1 (fr) 2020-03-26 2023-02-08 GlaxoSmithKline Intellectual Property Development Limited Inhibiteurs de cathepsine pour la prévention ou le traitement d'infections virales
WO2022106897A2 (fr) 2020-11-20 2022-05-27 2692372 Ontario, Inc. Procédés et composition pour effectuer des modifications de kras
KR20230147036A (ko) 2020-11-20 2023-10-20 2692372 온타리오 인크. 벤젠설폰아미드 유도체 및 이의 용도

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY1308A (en) 1979-12-06 1985-12-06 Glaxo Group Ltd Device for dispensing medicaments
DE3274065D1 (de) 1981-07-08 1986-12-11 Draco Ab Powder inhalator
CA1224992A (fr) 1982-10-08 1987-08-04 Robert E. Newell Dispositif pour l'administration d'un medicament a un patient
GB2169265B (en) 1982-10-08 1987-08-12 Glaxo Group Ltd Pack for medicament
US4778054A (en) 1982-10-08 1988-10-18 Glaxo Group Limited Pack for administering medicaments to patients
FR2585563B1 (fr) 1985-07-30 1993-11-12 Glaxo Group Ltd Dispositif pour administrer des medicaments a des patients
US6536427B2 (en) 1990-03-02 2003-03-25 Glaxo Group Limited Inhalation device
GB9004781D0 (en) 1990-03-02 1990-04-25 Glaxo Group Ltd Device
SK280968B6 (sk) 1990-03-02 2000-10-09 Glaxo Group Limited Balenie medikamentu na použite v inhalačnom prístroji
EE03997B1 (et) 1995-04-14 2003-04-15 Glaxo Wellcome Inc. Albuterooli doseeriv inhalaator
GB9700226D0 (en) 1997-01-08 1997-02-26 Glaxo Group Ltd Inhalation device
TW533865U (en) 1997-06-10 2003-05-21 Glaxo Group Ltd Dispenser for dispensing medicament and actuation indicating device
US6352152B1 (en) 1998-12-18 2002-03-05 Smithkline Beecham Corporation Method and package for storing a pressurized container containing a drug
US6119853A (en) 1998-12-18 2000-09-19 Glaxo Wellcome Inc. Method and package for storing a pressurized container containing a drug
US6390291B1 (en) 1998-12-18 2002-05-21 Smithkline Beecham Corporation Method and package for storing a pressurized container containing a drug
US6315112B1 (en) 1998-12-18 2001-11-13 Smithkline Beecham Corporation Method and package for storing a pressurized container containing a drug
US6372743B1 (en) 1999-09-30 2002-04-16 Neurogen Corporation Certain alkylene diamine-substituted pyrazlo (1,5-a)-1,5-pyrimidines and pyrazolo (1,5-a) 1,3,5-triazines
GB0201677D0 (en) 2002-01-25 2002-03-13 Glaxo Group Ltd Medicament dispenser
US7601724B2 (en) 2002-09-04 2009-10-13 Schering Corporation Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
WO2004022561A1 (fr) 2002-09-04 2004-03-18 Schering Corporation Pyrazolopyrimidines tenant lieu d'inhibiteurs de kinases dependantes de la cycline
GB0305559D0 (en) 2003-03-11 2003-04-16 Teijin Ltd Compounds
GB0317374D0 (en) 2003-07-24 2003-08-27 Glaxo Group Ltd Medicament dispenser
US7329662B2 (en) * 2003-10-03 2008-02-12 Hoffmann-La Roche Inc. Pyrazolo-pyridine
AU2004287261B8 (en) 2003-11-03 2011-01-27 Glaxo Group Limited A fluid dispensing device
MXPA06009133A (es) 2004-02-16 2007-01-26 Glaxo Group Ltd Contador para usarse con un distribuidor de medicamento.
GB0418278D0 (en) 2004-08-16 2004-09-15 Glaxo Group Ltd Medicament dispenser
GB0423653D0 (en) * 2004-10-25 2004-11-24 Piramed Ltd Pharmaceutical compounds
GB0515584D0 (en) 2005-07-28 2005-09-07 Glaxo Group Ltd Medicament dispenser
AR058289A1 (es) 2005-12-12 2008-01-30 Glaxo Group Ltd Colector para ser usado en dispensador de medicamento
GB0716292D0 (en) 2007-08-21 2007-09-26 Biofocus Dpi Ltd Imidazopyrazine compounds
TWI453207B (zh) * 2008-09-08 2014-09-21 Signal Pharm Llc 胺基***并吡啶，其組合物及使用其之治療方法
UA110324C2 (en) * 2009-07-02 2015-12-25 Genentech Inc Jak inhibitory compounds based on pyrazolo pyrimidine
EP2548877A1 (fr) * 2011-07-19 2013-01-23 MSD Oss B.V. Dérivés de 4-(pyridine condensée à 5 chaînons)benzamide comme inhibiteurs de BTK
EP2744332B1 (fr) * 2011-08-19 2016-10-26 Glaxo Group Limited Composés benzofuranes pour le traitement d'infections par le virus de l'hépatite c
GB201115665D0 (en) 2011-09-09 2011-10-26 Univ Leuven Kath Autoimmune and inflammatory disorder therapy
US8633198B1 (en) 2011-09-20 2014-01-21 Nant Holdings Ip, Llc Small molecule inhibitors of influenza A RNA-dependent RNA polymerase
EP2634190A1 (fr) 2012-03-01 2013-09-04 Lead Discovery Center GmbH dérivés de pyrazolo-triazine en tant qu'inhibiteurs des kinases dépendantes de la cycline
MY189182A (en) 2012-12-20 2022-01-31 Ucb Biopharma Sprl Therapeutically active pyrazolo-pyrimidine derivatives
WO2014113942A1 (fr) * 2013-01-23 2014-07-31 Merck Sharp & Dohme Corp. Inhibiteurs de btk
CN105189511B (zh) * 2013-03-13 2017-05-24 百时美施贵宝公司 人免疫缺陷病毒复制的抑制剂
US9963455B2 (en) 2014-01-22 2018-05-08 Curovir Ab Pyrazolo[1,5-a]pyrimidines as antiviral compounds
GB201410816D0 (en) 2014-06-17 2014-07-30 Ucb Biopharma Sprl And Katholieke Universiteit Leuven Therapeutic agents
GB201410817D0 (en) 2014-06-17 2014-07-30 Ucb Biopharma Sprl And Katholieke Universiteit Leuven K U Leuven R & D Therapeutic agents
GB201410815D0 (en) 2014-06-17 2014-07-30 Ucb Biopharma Sprl And Katholieke Universiteit Leuven Therapeutic agents
JP6689299B2 (ja) * 2015-06-24 2020-04-28 キュロヴィル・アクチボラグ 療法に有用なピラゾロ［１，５−ａ］トリアジン−４−アミン誘導体
GB201517263D0 (en) * 2015-09-30 2015-11-11 Ucb Biopharma Sprl And Katholieke Universiteit Leuven Therapeutic agents
AU2018209175B2 (en) 2017-01-17 2021-11-25 Michael David FORREST Therapeutic inhibitors of the reverse mode of ATP synthase
JP7161823B2 (ja) 2017-03-31 2022-10-27 ビーエーエスエフ ソシエタス・ヨーロピア 動物有害生物を駆除するためのピリミジニウム化合物及びそれらの混合物
CL2020000127A1 (es) 2017-07-13 2020-04-24 Michael David Forrest Moduladores terapéuticos del modo inverso de la atp sintasa.
MX2020007521A (es) * 2018-01-17 2022-12-05 Glaxosmithkline Ip Dev Ltd Inhibidores de pi4kiii.
IL275766B1 (en) 2018-01-17 2024-01-01 Aurigene Oncology Ltd Converted alkylene compounds as anticancer agents
MX2021004762A (es) 2018-10-29 2021-06-08 Nippon Soda Co Compuesto (hetero)arilimidazol y agente de control de organismos nocivos.
US11034693B2 (en) 2018-10-29 2021-06-15 MyoKardia, Inc. Substituted 5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine-2,4-diones for treating cardiac diseases

Also Published As

Publication number Publication date
AR114082A1 (es) 2020-07-22
MX2020007521A (es) 2022-12-05
PH12020551034A1 (en) 2021-09-06
EP3740489A1 (fr) 2020-11-25
WO2019141694A1 (fr) 2019-07-25
IL276013B1 (en) 2023-11-01
CA3088347A1 (fr) 2019-07-25
CN117069728A (zh) 2023-11-17
AU2019208416A1 (en) 2020-07-23
CO2020008887A2 (es) 2020-07-31
AU2019208416B2 (en) 2021-07-29
TW201940173A (zh) 2019-10-16
KR20200109343A (ko) 2020-09-22
KR102523513B1 (ko) 2023-04-18
RU2020123034A (ru) 2022-02-17
JP2021510711A (ja) 2021-04-30
TWI795510B (zh) 2023-03-11
IL276013B2 (en) 2024-03-01
JP7133023B2 (ja) 2022-09-07
US20230124394A1 (en) 2023-04-20
IL276013A (en) 2020-08-31
US20210387988A1 (en) 2021-12-16
US11649238B2 (en) 2023-05-16
BR112020014431A2 (pt) 2020-12-01
JP2022172223A (ja) 2022-11-15
CN111868063A (zh) 2020-10-30
CL2020001875A1 (es) 2021-02-12
SG11202006453SA (en) 2020-08-28
JP7338017B2 (ja) 2023-09-04
CN111868063B (zh) 2023-08-01
UY38051A (es) 2019-08-30

Similar Documents

Publication Publication Date Title
MA54543A (fr) Inhibiteurs de kif18a
MA54550A (fr) Inhibiteurs de kif18a
MA52413A (fr) Inhibiteurs de cd73
MA52812A (fr) Inhibiteurs de sarm1
MA53287A (fr) Inhibiteurs de prmt5
MA52635A (fr) Inhibiteurs de magl
DK3571192T3 (da) Jak1-selektive inhibitorer
DK3630744T3 (da) Pyrazol-magl-inhibitorer
MA51611A (fr) Inhibiteurs de pi4kiiibêta
MA52813A (fr) Inhibiteurs de sarm1
MA52809A (fr) Inhibiteurs de sarm1
DK3710457T3 (da) Immunproteasomhæmmere
DK3720840T3 (da) Cathepsinhæmmere
DK3587968T3 (da) Fluidsystem
MA49925A (fr) Claie
DE112019000442A5 (de) Ringtilgereinrichtung
NO20181678A1 (no) Rissanviser
JP1628555S (ja) たい焼
JP1628556S (ja) たい焼
ES1218724Y (es) Terrario
ES1224156Y (es) Ecobolsera
UA38411S (uk) Термокухоль
UA38602S (uk) Термокухоль
UA38606S (uk) Електролобзик
UA38598S (uk) Пневмофарбопульт